Expression of mitofusin 2R94Q in a transgenic mouse leads to Charcot-Marie-Tooth neuropathy type 2A

Brain

Volumn 133, Issue 5, 2010, Pages 1460-1469

  Cartoni, Romain ^a   Arnaud, Estelle ^b   Médard, Jean Jacques ^b   Poirot, Olivier ^b   Courvoisier, Delphine S ^c   Chrast, Roman ^b   Martinou, Jean Claude ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Charcot Marie Tooth type 2A; Mitochondrial fusion; Mitofusin 2; Mouse model; Transgenic mouse

Indexed keywords

COMPLEMENTARY DNA; MITOFUSIN 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SIZE; CONTROLLED STUDY; GAIT DISORDER; GENE EXPRESSION; GENE MUTATION; HEREDITARY MOTOR SENSORY NEUROPATHY; MITOCHONDRION; MOUSE; MUSCULOSKELETAL SYSTEM; MYELINATED NERVE; NERVE FIBER; NONHUMAN; PATHOPHYSIOLOGY; PERIPHERAL NERVOUS SYSTEM; PHENOTYPE; PRIORITY JOURNAL; SCIATIC NERVE;

AGING; ANIMALS; ARGININE; AXONS; CHARCOT-MARIE-TOOTH DISEASE; DNA, COMPLEMENTARY; GLUTAMINE; GTP PHOSPHOHYDROLASES; HUMANS; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, TRANSGENIC; MICROSCOPY, ELECTRON; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; MUTATION; NERVE FIBERS, MYELINATED; NEURONS; PERIPHERAL NERVES; PHENOTYPE; SCIATIC NERVE;

EID: 77951896551     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awq082     Document Type: Article

References (29)

1. Alexander C, Votruba M, Pesch UE, Thiselton DL, Mayer S, Moore A, et al. OPA1, encoding a dynamin-related GTPase, is mutated in auto-somal dominant optic atrophy linked to chromosome 3q28. Nat Genet 2000; 26: 211-215
2. Amati-Bonneau P, Milea D, Bonneau D, Chevrollier A, Ferre M, Guillet V, et al. OPA1-associated disorders: phenotypes and pathophy-siology. Int J Biochem Cell Biol 2009; 41: 1855-1865
3. Arnaud E, Zenker J, DePreux Charles A, Stendel C, Roos A, Medard J, et al. SH3TC2/KIAA1985 protein is required for proper myelination and the integrity of the node of Ranvier in the peripheral nervous system. Proc Natl Acad Sci USA 2009; 106: 17528-17533
4. Baloh RH, Schmidt RE, Pestronk A, Milbrandt J. Altered axonal mitochondrial transport in the pathogenesis of Charcot-Marie-Tooth disease from mitofusin 2 mutations. J Neurosci 2007; 27: 422-430
5. Cartoni R, Martinou JC. Role of mitofusin 2 mutations in the physio-pathology of Charcot-Marie-Tooth disease type 2A. Exp Neurol 2009; 218: 268-273
6. Cartoni R, Leger B, Hock MB, Praz M, Crettenand A, Pich S, et al. Mitofusins 1/2 and ERRalpha expression are increased in human skeletal muscle after physical exercise. J Physiol 2005; 567: 349-358
7. Chan DC. Mitochondrial fusion and fission in mammals. Annu Rev Cell Dev Biol 2006; 22: 79-99.
8. Chen H, Detmer SA, Ewald AJ, Griffin EE, Fraser SE, Chan DC. Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development. J Cell Biol 2003; 160: 189-200.
9. Chen H, McCaffery JM, Chan DC. Mitochondrial fusion protects against neurodegeneration in the cerebellum. Cell 2007; 130: 548-562
10. Chung KW, Kim SB, Park KD, Choi KG, Lee JH, Eun HW, et al. Early onset severe and late-onset mild Charcot-Marie-Tooth disease with mitofusin 2 (MFN2) mutations. Brain 2006; 129: 2103-2118
11. Delettre C, Lenaers G, Griffoin JM, Gigarel N, Lorenzo C, Belenguer P, et al. Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat Genet 2000; 26: 207-210
12. Detmer SA, Chan DC. Complementation between mouse Mfn1 and Mfn2 protects mitochondrial fusion defects caused by CMT2A disease mutations. J Cell Biol 2007a; 176: 405-414
13. Detmer SA, Chan DC. Functions and dysfunctions of mitochondrial dynamics. Nat Rev Mol Cell Biol 2007b; 8: 870-879
14. Detmer SA, Vande Velde C, Cleveland DW, Chan DC. Hindlimb gait defects due to motor axon loss and reduced distal muscles in a trans-genic mouse model of Charcot-Marie-Tooth type 2A. Hum Mol Genet 2008; 17: 367-375
15. Eura Y, Ishihara N, Yokota S, Mihara K. Two mitofusin proteins, mammalian homologues of FZO, with distinct functions are both required for mitochondrial fusion. J Biochem (Tokyo) 2003; 134: 333-344
16. Forss-Petter S, Danielson PE, Catsicas S, Battenberg E, Price J, Nerenberg M, et al. Transgenic mice expressing beta-galactosidase in mature neurons under neuron-specific enolase promoter control. Neuron 1990; 5: 187-197
17. Funalot B, Magdelaine C, Sturtz F, Ouvrier R, Vallat JM. Ultrastructural lesions of axonal mitochondria in patients with childhood-onset Charcot-Marie-Tooth disease due to MFN2 mutations. Bull Acad Natl Med 2009; 193: 151-60; discussion 160-161
18. Keynes RD, Aidley DJ. Nerve and Muscle. Cambridge: Cambridge University Press; 2001.
19. Kijima K, Numakura C, Izumino H, Umetsu K, Nezu A, Shiiki T, et al. Mitochondrial GTPase mitofusin 2 mutation in Charcot-Marie-Tooth neuropathy type 2A. Hum Genet 2005; 116: 23-27
20. Martinou JC, Dubois-Dauphin M, Staple JK, Rodriguez I, Frankowski H, Missotten M, et al. Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron 1994; 13: 1017-1030
21. Scherer SS, Wrabetz L. Molecular mechanisms of inherited demyelinating neuropathies. Glia 2008; 56: 1578-1589
22. Schrö der JM. Pathology of peripheral nerves: an atlas of structural and molecular pathological changes. Berlin: Springer; 2001.
23. Seburn KL, Nangle LA, Cox GA, Schimmel P, Burgess RW. An active dominant mutation of glycyl-tRNA synthetase causes neuropathy in a Charcot-Marie-Tooth 2D mouse model. Neuron 2006; 51: 715-726
24. Skre H. Genetic and clinical aspects of Charcot-Marie-Tooth's disease. Clin Genet 1974; 6: 98-118.
25. Stys PK, Ransom BR, Waxman SG. Compound action potential of nerve recorded by suction electrode: a theoretical and experimental analysis. Brain Res 1991; 546: 18-32.
26. Vallat JM, Ouvrier RA, Pollard JD, Magdelaine C, Zhu D, Nicholson GA, et al. Histopathological findings in hereditary motor and sensory neuropathy of axonal type with onset in early childhood associated with mitofusin 2 mutations. J Neuropathol Exp Neurol 2008; 67: 1097-1102
27. Verhoeven K, Claeys KG, Zuchner S, Schroder JM, Weis J, Ceuterick C, et al. MFN2 mutation distribution and genotype/phenotype correlation in Charcot-Marie-Tooth type 2. Brain 2006; 129: 2093-2102
28. Waxman SG, Kocsis JD, Stys PK. The axon:structure, function and pathophysiology. New York: Oxford: Oxford University Press; 1995.
29. Zuchner S, Mersiyanova IV, Muglia M, Bissar-Tadmouri N, Rochelle J, Dadali EL, et al. Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat Genet 2004; 36: 449-451